Structure-activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2018-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2018.03.015PMID 29580851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vivo Near-Infrared Fluorescence Imaging

  2018cited by this paper
• Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.

  2017cited by this paper
• Cancer statistics, 2017

  2017cited by this paper
• Synthesis and evaluation of a novel near-infrared fluorescent probe based on succinimidyl-Cys-C(O)-Glu that targets prostate-specific membrane antigen for optical imaging.

  2017cited by this paper
• Next generation NIR fluorophores for tumor imaging and fluorescence-guided surgery: A review.

  2017cited by this paper
• PSMA-targeted contrast agents for intraoperative imaging of prostate cancer.

  2017influential reference
• Visible to Near-Infrared Fluorescence Enhanced Cellular Imaging on Plasmonic Gold Chips.

  2016cited by this paper
• Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report

  2016cited by this paper
• In vivo sensing of proteolytic activity with an NSET-based NIR fluorogenic nanosensor.

  2016cited by this paper
• F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients

  2016cited by this paper
• Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer

  2016cited by this paper
• Development of (99m)Tc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging.

  2016cited by this paper
• Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

  2015cited by this paper
• Prostate-specific membrane antigen as a target for cancer imaging and therapy.

  2015cited by this paper
• Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

  2015cited by this paper
• Labeling of active proteases in fresh-frozen tissues by topical application of quenched activity-based probes

  2015cited by this paper
• Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide

  2014cited by this paper
• Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer

  2014influential reference
• A Broad Nanoparticle-Based Strategy for Tumor Imaging by Nonlinear Amplification of Microenvironment Signals

  2013cited by this paper
• Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.

  2013cited by this paper
• 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.

  2012cited by this paper
• Near infrared fluorescence for image-guided surgery.

  2012cited by this paper
• Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.

  2012cited by this paper
• Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

  2011cited by this paper
• Developing imaging strategies for castration resistant prostate cancer

  2011cited by this paper
• A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.

  2010cited by this paper
• A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.

  2010cited by this paper
• Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats

  2010cited by this paper
• Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.

  2010cited by this paper
• Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting.

  2009cited by this paper
• Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?

  2008cited by this paper
• Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

  2008cited by this paper
• Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.

  2007cited by this paper
• Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

  2006cited by this paper
• Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer

  2005cited by this paper
• Androgen receptor modifications in prostate cancer cells upon long‐termandrogen ablation and antiandrogen treatment

  2005cited by this paper
• Recurrence‐free survival rates after external‐beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate‐specific antigen era

  2004cited by this paper
• Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database.

  2003cited by this paper
• In vivo near-infrared fluorescence imaging.

  2003cited by this paper
• Fluorescence and Absorption Contrast Mechanisms for Biomedical Optical Imaging Using Frequency‐Domain Techniques

  1997cited by this paper
• Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.

  1997influential reference
• Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy.

  1996influential reference
• Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues.

  1995cited by this paper
• Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.

  1995influential reference
• Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy

  1995cited by this paper
• Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.

  1993cited by this paper
• Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters.

  1993cited by this paper
• Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.

  1987cited by this paper

• Engineering NIR Probes to Enhance Affinity and Clinical Workflow Compatibility for Prostate Cancer Imaging.

  2025cites this paper
• Engineering NIR probes to enhance affinity and clinical workflow compatibility for prostate cancer imaging

  2025cites this paper
• Evaluation of Indocyanine Green Derivatives with Sulfonic Acid and Carboxylic Acid Groups at the Benzoindolenine Moiety for Antibody-Based Tumor Imaging

  2025cites this paper
• A cell-impermeable luminogenic probe for near-infrared imaging of prostate-specific membrane antigen in prostate cancer microenvironments.

  2023cites this paper
• Advances in Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Phototheranostics of Prostate Cancer

  2022cites this paper
• The application of indocyanine green in guiding prostate cancer treatment

  2022cites this paper
• Affinity probes based on small-molecule inhibitors for tumor imaging

  2022cites this paper
• Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.

  2021cites this paper
• Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye–Protein Interaction

  2020cites this paper
• GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond.

  2019cites this paper
• Near-infrared-emitting GdVO4:Nd,Yb nanophosphors synthesized by microreaction method for biological imaging

  2018cites this paper
• Image-, fluorescence- and radio-guided navigation for identification and localization of lymph node metastasesin prostate cancer

  2018cites this paper